GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
7 hedge funds and large institutions have $469K invested in Amplify Treatments, Testing and Advancements ETF in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WS
1
Wedbush Securities
Los Angeles,
California
| $255K | +$255K | +8,940 | New |
|
|
BSG
2
Black Swift Group
Boulder,
Colorado
| $143K | +$143K | +5,000 | New |
|
|
SFS
3
Sowell Financial Services
North Little Rock,
Arkansas
| $48K | +$48K | +1,680 | New |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | +$11K | +385 | New |
|
|
PIMG
5
Patriot Investment Management Group
Knoxville,
Tennessee
| $5.71K | +$5.71K | +200 | New |
|
|
TWA
6
TCI Wealth Advisors
Tucson,
Arizona
| $4K | +$4K | +140 | New |
|
|
GWM
7
Geneos Wealth Management
Englewood,
Colorado
| $2K | +$2K | +100 | New |
|